TY  - CONF

T1  - Denosumab versus placebo as adjuvant treatment for women with early-stage breast cancer who are at high risk of disease recurrence (D-CARE): An international, randomized, double-blind, placebo-controlled phase III clinical trial.

JO  - JOURNAL OF CLINICAL ONCOLOGY

PY  - 2012/05/20

AU  - Goss PE

AU  - Barrios CH

AU  - Bell R

AU  - Finkelstein DM

AU  - Iwata H

AU  - Martin M

AU  - Braun AH

AU  - Ke C

AU  - Maniar T

AU  - Coleman RE

ED  - 

VL  - 30

IS  - 15

Y2  - 2025/10/10

ER  -